Arvinas ARVN
NASDAQ ARVN
$6.91 -0.01 (-0.14%)
At close: Nov 11, 2026 · 4:00 PM EST

Arvinas (ARVN) EBIT Margin (2017 - 2026)

Updated

Arvinas (ARVN) recorded EBIT Margin of -11820.00% in Q3 2026, down 11715.47 percentage points from -104.53% a year earlier and down 11885.72 percentage points from the prior quarter.

Analysis

Arvinas (ARVN) EBIT Margin (2017 - 2026) Analysis & Trends

On a TTM basis, Arvinas' EBIT Margin came in at -12.13% as of Sep 30, 2026, up 20.56 percentage points year-over-year; for FY2025, it was -45.13%, up 49.86 percentage points from FY2024.

  • Annual EBIT Margin has a five-year change of +421.28 percentage points (FY2020 to FY2025).
  • Across earlier years, EBIT Margin came in at -94.99% in FY2024 (+416.48 pp), -511.46% in FY2023 (-311.16 pp), -200.30% in FY2022 (+151.19 pp) and -351.49% in FY2021 (+114.92 pp).
  • The Q3 2026 figure is the lowest quarterly EBIT Margin in data going back to Q1 2017.
  • On a year-over-year basis, EBIT Margin rose in two of the last seven quarters, with an average year-over-year change of -1771.24 percentage points.
  • Peak year-over-year performance for EBIT Margin in the last five years was a gain of 748.96 percentage points in Q2 2022, against a drop of 11715.47 percentage points in Q3 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at 65.72% (Q2 2026), -408.97% (Q1 2026) and -785.26% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Arvinas 453.26 Mn -1.97 Bn 400,000.00 -11,820.00%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -11,820.00%
Jun 30, 2026 65.72%
Mar 31, 2026 -408.97%
Dec 31, 2025 -785.26%
Sep 30, 2025 -104.53%
Jun 30, 2025 -319.20%
Mar 31, 2025 37.82%
Dec 31, 2024 -98.31%
Sep 30, 2024 -58.89%
Jun 30, 2024 -63.40%
Mar 31, 2024 -329.25%
Sep 30, 2023 -213.58%
Jun 30, 2023 -136.88%
Mar 31, 2023 -269.85%
Dec 31, 2022 -200.00%
Sep 30, 2022 -193.67%
Jun 30, 2022 -194.67%
Mar 31, 2022 -217.74%
Dec 31, 2021 -143.07%
Sep 30, 2021 -508.60%
API Access

Arvinas EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ARVN&period=max&api_key=YOUR_API_KEY